{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T15:16:05Z","timestamp":1790608565336,"version":"4.1.0"},"reference-count":70,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.jconrel.2012.05.023","type":"journal-article","created":{"date-parts":[[2012,5,18]],"date-time":"2012-05-18T05:01:37Z","timestamp":1337317297000},"page":"835-842","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Defeating Leishmania resistance to Miltefosine (hexadecylphosphocholine) by peptide-mediated drug smuggling: A proof of mechanism for trypanosomatid chemotherapy"],"prefix":"10.1016","volume":"161","author":[{"given":"Juan Rom\u00e1n","family":"Luque-Ortega","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz G.","family":"de la Torre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valent\u00edn","family":"Hornillos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Mathieu","family":"Bart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Rueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Amat-Guerri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Ulises","family":"Acu\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Andreu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Rivas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2012.05.023_bb0355","first-page":"1","article-title":"Control of the leishmaniases","volume":"xii-xiii","year":"2010","journal-title":"World Health Organ. Tech. Rep. Ser."},{"key":"10.1016\/j.jconrel.2012.05.023_bb0010","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nrmicro1748","article-title":"Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?","volume":"5","author":"Chappuis","year":"2007","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.jconrel.2012.05.023_bb0015","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1517\/14728210903153862","article-title":"Developments in the treatment of visceral leishmaniasis","volume":"14","author":"den Boer","year":"2009","journal-title":"Expert Opin. Emerg. Drugs"},{"key":"10.1016\/j.jconrel.2012.05.023_bb0020","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S1473-3099(10)70011-6","article-title":"Combination therapy for visceral leishmaniasis","volume":"10","author":"van Griensven","year":"2010","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.jconrel.2012.05.023_bb0025","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1128\/AAC.47.8.2397-2403.2003","article-title":"Leishmania donovani resistance to miltefosine involves a defective inward translocation of the drug","volume":"47","author":"P\u00e9rez-Victoria","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jconrel.2012.05.023_bb0030","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ijantimicag.2007.05.007","article-title":"Inactivation of the miltefosine transporter, LdMT, causes miltefosine resistance that is conferred to the amastigote stage of Leishmania donovani and persists in vivo","volume":"30","author":"Seifert","year":"2007","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.jconrel.2012.05.023_bb0035","doi-asserted-by":"crossref","first-page":"e201","DOI":"10.1038\/cddis.2011.83","article-title":"Tolerance to drug-induced cell death favours the acquisition of multidrug resistance in Leishmania","volume":"2","author":"Moreira","year":"2011","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jconrel.2012.05.023_bb0040","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1128\/AAC.01233-08","article-title":"In vitro susceptibility of field isolates of Leishmania donovani to Miltefosine and amphotericin B: correlation with sodium antimony gluconate susceptibility and implications for treatment in areas of endemicity","volume":"53","author":"Kumar","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jconrel.2012.05.023_bb0045","doi-asserted-by":"crossref","first-page":"49965","DOI":"10.1074\/jbc.M308352200","article-title":"Functional cloning of the miltefosine transporter. A novel P-type phospholipid translocase from Leishmania involved in drug resistance","volume":"278","author":"P\u00e9rez-Victoria","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2012.05.023_bb0050","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1128\/AAC.00423-06","article-title":"Combination of suboptimal doses of inhibitors targeting different domains of LtrMDR1 efficiently overcomes resistance of Leishmania spp. to Miltefosine by inhibiting drug efflux","volume":"50","author":"P\u00e9rez-Victoria","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jconrel.2012.05.023_bb0055","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1128\/AAC.01694-08","article-title":"Low plasma membrane expression of the miltefosine transport complex renders Leishmania braziliensis refractory to the drug","volume":"53","author":"S\u00e1nchez-Ca\u00f1ete","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jconrel.2012.05.023_bb0060","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nrd3187","article-title":"Coexistence of passive and carrier-mediated processes in drug transport","volume":"9","author":"Sugano","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2012.05.023_bb0065","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/iub.297","article-title":"Cell-penetrating peptides: nanocarrier for macromolecule delivery in living cells","volume":"62","author":"Chugh","year":"2010","journal-title":"IUBMB Life"},{"key":"10.1016\/j.jconrel.2012.05.023_bb0070","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.2174\/092986711795029591","article-title":"The delivery of biologically active (therapeutic) peptides and proteins into cells","volume":"18","author":"Grdisa","year":"2011","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jconrel.2012.05.023_bb0075","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.addr.2009.06.001","article-title":"Recent advances in the use of cell-penetrating peptides for medical and biological applications","volume":"61","author":"Fonseca","year":"2009","journal-title":"Adv. Drug Deliv."},{"key":"10.1016\/j.jconrel.2012.05.023_bb0080","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-60761-919-2_1","article-title":"Classes and prediction of cell-penetrating peptides","volume":"683","author":"Lindgren","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jconrel.2012.05.023_bb0085","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/978-1-60761-919-2_39","article-title":"Nonclinical and clinical experiences with CPP-based self-assembling peptide systems in topical drug development","volume":"683","author":"Waugh","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jconrel.2012.05.023_bb0090","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/1475-2875-9-258","article-title":"CPP-ZFN: a potential DNA-targeting anti-malarial drug","volume":"9","author":"Nain","year":"2010","journal-title":"Malar. J."},{"key":"10.1016\/j.jconrel.2012.05.023_bb0095","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/j.bbamem.2008.11.002","article-title":"Amphibian antimicrobial peptides and Protozoa: lessons from parasites","volume":"1788","author":"Rivas","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jconrel.2012.05.023_bb0100","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.addr.2009.11.024","article-title":"Nanotechnology applied to the treatment of malaria","volume":"62","author":"Santos-Magalhaes","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2012.05.023_bb0105","doi-asserted-by":"crossref","first-page":"6336","DOI":"10.1016\/j.bmcl.2008.10.089","article-title":"Synthesis of BODIPY-labeled alkylphosphocholines with leishmanicidal activity, as fluorescent analogues of miltefosine","volume":"18","author":"Hornillos","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.jconrel.2012.05.023_bb0110","doi-asserted-by":"crossref","first-page":"5190","DOI":"10.1016\/j.bmcl.2006.07.004","article-title":"Synthesis of 16-mercaptohexadecylphosphocholine, a miltefosine analog with leishmanicidal activity","volume":"16","author":"Hornillos","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.jconrel.2012.05.023_bb0115","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/978-1-60761-594-1_25","article-title":"Characterization of the leishmanicidal activity of antimicrobial peptides","volume":"618","author":"Luque-Ortega","year":"2010","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jconrel.2012.05.023_bb0120","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1093\/emboj\/18.8.2265","article-title":"Trypanosoma brucei variant surface glycoprotein regulation involves coupled activation\/inactivation and chromatin remodeling of expression sites","volume":"18","author":"Navarro","year":"1999","journal-title":"EMBO J."},{"key":"10.1016\/j.jconrel.2012.05.023_bb0125","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1128\/AAC.48.5.1534-1540.2004","article-title":"Fungus-elicited metabolites from plants as an enriched source for new leishmanicidal agents: antifungal phenyl-phenalenone phytoalexins from the banana plant (Musa acuminata) target mitochondria of Leishmania donovani promastigotes","volume":"48","author":"Luque-Ortega","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jconrel.2012.05.023_bb0130","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1128\/AAC.45.4.1121-1125.2001","article-title":"In vivo monitoring of intracellular ATP levels in Leishmania donovani promastigotes as a rapid method to screen drugs targeting bioenergetic metabolism","volume":"45","author":"Luque-Ortega","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jconrel.2012.05.023_bb0135","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1091\/mbc.e02-10-0640","article-title":"Endocytosis of a glycosylphosphatidylinositol-anchored protein via clathrin-coated vesicles, sorting by default in endosomes, and exocytosis via RAB11-positive carriers","volume":"14","author":"Grunfelder","year":"2003","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.jconrel.2012.05.023_bb0140","doi-asserted-by":"crossref","first-page":"5994","DOI":"10.1021\/jm070595+","article-title":"Synthesis and biological evaluation of fluorescent leishmanicidal analogues of hexadecylphosphocholine (miltefosine) as probes of antiparasite mechanisms","volume":"50","author":"Saugar","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jconrel.2012.05.023_bb0145","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0166-6851(89)90183-7","article-title":"Maintenance of cytoplasmic pH and proton motive force in promastigotes of Leishmania donovani","volume":"36","author":"Zilberstein","year":"1989","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.jconrel.2012.05.023_bb0150","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1128\/AAC.45.9.2468-2474.2001","article-title":"Alkyl-lysophospholipid resistance in multidrug-resistant Leishmania tropica and chemosensitization by a novel P-glycoprotein-like transporter modulator","volume":"45","author":"P\u00e9rez-Victoria","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jconrel.2012.05.023_bb0155","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.addr.2004.12.001","article-title":"Tat peptide-mediated cellular delivery: back to basics","volume":"57","author":"Brooks","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2012.05.023_bb0160","doi-asserted-by":"crossref","first-page":"33957","DOI":"10.1074\/jbc.M109.056309","article-title":"Translocation and endocytosis for cell-penetrating peptide internalization","volume":"284","author":"Jiao","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2012.05.023_bb0165","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1093\/jac\/38.6.1041","article-title":"The activities of four anticancer alkyllysophospholipids against Leishmania donovani, Trypanosoma cruzi and Trypanosoma brucei","volume":"38","author":"Croft","year":"1996","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jconrel.2012.05.023_bb0170","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/cdd.2008.161","article-title":"Neuropeptides kill African trypanosomes by targeting intracellular compartments and inducing autophagic-like cell death","volume":"16","author":"Delgado","year":"2009","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.jconrel.2012.05.023_bb0175","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1021\/mp100035f","article-title":"The antitumoral depsipeptide IB-01212 kills Leishmania through an apoptosis-like process involving intracellular targets","volume":"7","author":"Luque-Ortega","year":"2010","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2012.05.023_bb0180","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1096\/fj.07-096081","article-title":"Human antimicrobial peptide histatin 5 is a cell-penetrating peptide targeting mitochondrial ATP synthesis in Leishmania","volume":"22","author":"Luque-Ortega","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.jconrel.2012.05.023_bb0185","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.1128\/AAC.01450-07","article-title":"Cell-penetrating peptide TP10 shows broad-spectrum activity against both Plasmodium falciparum and Trypanosoma brucei brucei","volume":"52","author":"Arrighi","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jconrel.2012.05.023_bb0190","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1042\/bj20020386","article-title":"Novel peptide inhibitors of Leishmania gp63 based on the cleavage site of MARCKS (myristoylated alanine-rich C kinase substrate)-related protein","volume":"367","author":"Corradin","year":"2002","journal-title":"Biochem. J."},{"key":"10.1016\/j.jconrel.2012.05.023_bb0195","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1016\/j.bbamem.2010.07.023","article-title":"Daunomycin-polypeptide conjugates with antitumor activity","volume":"1798","author":"Szabo","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jconrel.2012.05.023_bb0200","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.bcp.2005.10.048","article-title":"Overcoming methotrexate resistance in breast cancer tumour cells by the use of a new cell-penetrating peptide","volume":"71","author":"Lindgren","year":"2006","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jconrel.2012.05.023_bb0205","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1007\/s10495-009-0397-8","article-title":"Conjugation of doxorubicin to cell penetrating peptides sensitizes human breast MDA-MB 231 cancer cells to endogenous TRAIL-induced apoptosis","volume":"14","author":"Aroui","year":"2009","journal-title":"Apoptosis"},{"key":"10.1016\/j.jconrel.2012.05.023_bb0210","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3109\/10611860903548347","article-title":"Reduction of doxorubicin resistance in P-glycoprotein overexpressing cells by hybrid cell-penetrating and drug-binding peptide","volume":"18","author":"Zheng","year":"2010","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2012.05.023_bb0215","first-page":"990","article-title":"Effective antibacterial action of tat (47\u201358) by increased uptake into bacterial cells in the presence of trypsin","volume":"18","author":"Jung","year":"2008","journal-title":"J. Microbiol. Biotechnol."},{"key":"10.1016\/j.jconrel.2012.05.023_bb0220","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.bbrc.2006.04.059","article-title":"Biological activity of Tat (47\u201358) peptide on human pathogenic fungi","volume":"345","author":"Jung","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jconrel.2012.05.023_bb0225","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/psc.1120","article-title":"Effects of dimerization of the cell-penetrating peptide Tat analog on antimicrobial activity and mechanism of bactericidal action","volume":"15","author":"Zhu","year":"2009","journal-title":"J. Pept. Sci."},{"key":"10.1016\/j.jconrel.2012.05.023_bb0230","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00436-006-0189-9","article-title":"Endocytic portals in Trypanosoma cruzi epimastigote forms","volume":"99","author":"Soares","year":"2006","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.jconrel.2012.05.023_bb0235","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.1093\/emboj\/cdg481","article-title":"Clathrin-mediated endocytosis is essential in Trypanosoma brucei","volume":"22","author":"Allen","year":"2003","journal-title":"EMBO J."},{"key":"10.1016\/j.jconrel.2012.05.023_bb0240","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1365-2958.2004.04224.x","article-title":"Endocytosis, membrane recycling and sorting of GPI-anchored proteins: Trypanosoma brucei as a model system","volume":"53","author":"Over\u00e4th","year":"2004","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.jconrel.2012.05.023_bb0245","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1042\/BST0350788","article-title":"Cell-surface proteoglycans as molecular portals for cationic peptide and polymer entry into cells","volume":"35","author":"Poon","year":"2007","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.jconrel.2012.05.023_bb0250","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1529\/biophysj.107.113472","article-title":"Binding and clustering of glycosaminoglycans: a common property of mono- and multivalent cell-penetrating compounds","volume":"94","author":"Ziegler","year":"2008","journal-title":"Biophys. J."},{"key":"10.1016\/j.jconrel.2012.05.023_bb0255","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1074\/jbc.M109.021964","article-title":"Revised role of glycosaminoglycans in TAT protein transduction domain-mediated cellular transduction","volume":"285","author":"Gump","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2012.05.023_bb0260","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jconrel.2011.03.011","article-title":"Penetration without cells: membrane translocation of cell-penetrating peptides in the model giant plasma membrane vesicles","volume":"153","author":"Saalik","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2012.05.023_bb0265","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1096\/fj.05-5523com","article-title":"Cargo-dependent mode of uptake and bioavailability of TAT-containing proteins and peptides in living cells","volume":"20","author":"Tunnemann","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.jconrel.2012.05.023_bb0270","doi-asserted-by":"crossref","first-page":"e12443","DOI":"10.1371\/journal.pone.0012443","article-title":"Disruption of the lipid-transporting LdMT-LdRos3 complex in Leishmania donovani affects membrane lipid asymmetry but not host cell invasion","volume":"5","author":"Weingartner","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2012.05.023_bb0275","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1002\/cphc.200600306","article-title":"The cell-penetrating peptide TAT(48\u201360) induces a non-lamellar phase in DMPC membranes","volume":"7","author":"Afonin","year":"2006","journal-title":"Chemphyschem"},{"key":"10.1016\/j.jconrel.2012.05.023_bb0280","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.bbrc.2004.04.121","article-title":"Biodistribution of intracellularly acting peptides conjugated reversibly to Tat","volume":"318","author":"Begley","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jconrel.2012.05.023_bb0285","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0169-409X(02)00179-5","article-title":"Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities","volume":"55","author":"Saito","year":"2003","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2012.05.023_bb0290","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ijpharm.2008.10.036","article-title":"Disulfide and thioether linked cytochrome c-oligoarginine conjugates in HeLa cells","volume":"369","author":"Barnes","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2012.05.023_bb0295","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.1096\/fj.08-127563","article-title":"Cell-surface thiols affect cell entry of disulfide-conjugated peptides","volume":"23","author":"Aubry","year":"2009","journal-title":"FASEB J."},{"key":"10.1016\/j.jconrel.2012.05.023_bb0300","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0166-6851(02)00283-9","article-title":"Antiprotozoal activities of phospholipid analogues","volume":"126","author":"Croft","year":"2003","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.jconrel.2012.05.023_bb0305","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1128\/AAC.01415-06","article-title":"Miltefosine (hexadecylphosphocholine) inhibits cytochrome c oxidase in Leishmania donovani promastigotes","volume":"51","author":"Luque-Ortega","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jconrel.2012.05.023_bb0310","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1111\/j.1365-2958.2010.07151.x","article-title":"The essential neutral sphingomyelinase is involved in the trafficking of the variant surface glycoprotein in the bloodstream form of Trypanosoma brucei","volume":"76","author":"Young","year":"2010","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.jconrel.2012.05.023_bb0315","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1111\/j.1365-2958.2007.05653.x","article-title":"A novel ATP-binding cassette transporter from Leishmania is involved in transport of phosphatidylcholine analogues and resistance to alkyl-phospholipids","volume":"64","author":"Castanys-Mu\u00f1oz","year":"2007","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.jconrel.2012.05.023_bb0320","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1128\/AAC.00587-08","article-title":"Characterization of an ABCG-like transporter from the protozoan parasite Leishmania with a role in drug resistance and transbilayer lipid movement","volume":"52","author":"Castanys-Munoz","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jconrel.2012.05.023_bb0325","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.tips.2010.07.006","article-title":"In vivo biodistribution and efficacy of peptide mediated delivery","volume":"31","author":"Jarver","year":"2010","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.jconrel.2012.05.023_bb0330","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/jmr.639","article-title":"Drug targeting by macromolecules without recognition unit?","volume":"16","author":"Hudecz","year":"2003","journal-title":"J. Mol Recognit."},{"key":"10.1016\/j.jconrel.2012.05.023_bb0335","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1021\/bc015530e","article-title":"Methotrexate conjugate with branched polypeptide influences Leishmania donovani infection in vitro and in experimental animals","volume":"13","author":"Koczan","year":"2002","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2012.05.023_bb0340","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1021\/bc900577e","article-title":"S4(13)-PV cell-penetrating peptide forms nanoparticle-like structures to gain entry into cells","volume":"21","author":"Padari","year":"2010","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2012.05.023_bb0345","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/marc.200900861","article-title":"Efficient liposomal nanocarrier-mediated oligodeoxynucleotide delivery involving dual use of a cell-penetrating peptide as a packaging and intracellular delivery agent","volume":"31","author":"Saw","year":"2010","journal-title":"Macromol. Rapid Commun."},{"key":"10.1016\/j.jconrel.2012.05.023_bb0350","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jconrel.2006.12.008","article-title":"TAT peptide-based micelle system for potential active targeting of anti-cancer agents to acidic solid tumors","volume":"118","author":"Sethuraman","year":"2007","journal-title":"J. Control. Release"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365912004038?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365912004038?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:27:40Z","timestamp":1759159660000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365912004038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":70,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S0168365912004038"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2012.05.023","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Defeating Leishmania resistance to Miltefosine (hexadecylphosphocholine) by peptide-mediated drug smuggling: A proof of mechanism for trypanosomatid chemotherapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2012.05.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}